1 Choose the site
The accountability that comes from community involvement often complements the clinical accountability that IVIM weekly monitoring provides
This includes individuals with: Diagnosed MASLD or MASH, where GLP-1 therapy may offer therapeutic benefits but requires monitoring Chronic viral hepatitis (hepatitis B or C), particularly if transaminases are elevated Autoimmune hepatitis or other inflammatory liver conditions Cirrhosis or advanced fibrosis, where specialist consultation may be appropriate despite generally not requiring dose adjustment History of drug-induced liver injury from other agents For these patients, baseline comprehensive liver assessmentincluding liver enzymes, synthetic function tests (albumin, INR), and potentially imaging or non-invasive fibrosis markers (such as FIB-4 or ELF)helps establish a reference point for monitoring treatment effects
And once you stop, it takes roughly 5 half-lives, or about 35 days, for the medication to clear your system completely
Each unit marking represents a larger physical distance on the barrel, making it easier to draw precise small volumes
The GLP-1 receptors may already be partially desensitized from semaglutide use, but the GIP receptors are "fresh" and fully responsive